Sodium Valproate & Valproic Acid

Get a Price/Quote

Sodium Valproate & Valproic Acid Specification

Drug Type
Specific Drug

Ingredients
Kaypon (200) SR : Sodium Valproate 133 mg + Valproic Acid 58 mg= 200 SR Kaypon (300) SR : Sodium Valproate 200 mg + Valproic Acid 87 mg= 300 SR Kaypon (500) SR : Sodium Valproate 333 mg + Valproic Acid 145 mg= 500 SR

Physical Form
Tablets

Function
Other

Suitable For
Adults, Aged Person

Sodium Valproate & Valproic Acid Trade Information

Payment Terms
Cheque, Western Union, Paypal, Cash in Advance (CID), Cash Advance (CA)

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Alu-Alu,10*10 tablet Packing

Main Export Market(s)
Australia, South America, Eastern Europe, Western Europe, Middle East, Central America, Asia, North America, Africa

Main Domestic Market
All India

Certifications
WHO-GMP

About Sodium Valproate & Valproic Acid

Sodium Valproate & Valproic Acid tablets, available in sustained-release forms (200 SR, 300 SR, and 500 SR), are specifically formulated to provide optimal therapeutic effects for adults and aged individuals. Designed to manage various neurological and psychiatric conditions, these tablets combine Sodium Valproate and Valproic Acid in precise ratios for efficient drug release and sustained action. Kaypon 200 SR contains 133 mg of Sodium Valproate and 58 mg of Valproic Acid, while Kaypon 300 SR contains 200 mg of Sodium Valproate and 87 mg of Valproic Acid. For higher doses, Kaypon 500 SR delivers 333 mg of Sodium Valproate combined with 145 mg of Valproic Acid. Manufactured in tablet form, these drugs are exported, supplied, and produced to meet stringent quality standards, ensuring safety and efficacy for patients. Their sustained-release formulation helps maintain therapeutic drug levels, reducing dosing frequency and improving patient compliance.